Montelukast Arrow Lab

Montelukast, the active ingredient in Montelukast Arrow Lab, is a leukotriene receptor antagonist presented as an oral tablet for oral use. It is used to manage asthma, allergic rhinitis, and exercise‑induced bronchoconstriction in adults and children as directed by a healthcare professional. It is indicated for long‑term control of symptoms and is not intended for immediate relief of acute asthma attacks.

GNH USA supplies Montelukast Arrow Lab as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support global distribution.

Montelukast is a leukotriene receptor antagonist used to treat conditions mediated by leukotrienes.

- Asthma: improves long‑term control of symptoms and reduces exacerbations. - Allergic rhinitis: alleviates nasal congestion, sneezing and itching. - Exercise‑induced bronchoconstriction: prevents airway narrowing triggered by physical activity.

Montelukast may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Headache - Abdominal pain - Cough - Sore throat - Nausea - Dizziness

Serious or Rare Side Effects: - Allergic reactions such as rash or angioedema - Neuropsychiatric events including agitation, depression or suicidal thoughts - Elevated liver enzymes - Severe skin reactions like Stevens‑Johnson syndrome - Eosinophilic granulomatosis with polyangiitis - Anaphylaxis

When prescribing Montelukast, several safety considerations should be observed.

- Pregnancy: safety not established; use only if benefit outweighs risk. - Breastfeeding: unknown; consider risk versus benefit. - Pediatric use: approved for children as young as 6 months for certain indications; follow prescriber guidance. - Drug interactions: review concomitant medications, especially phenobarbital and rifampin. - Monitoring: observe for mood changes or allergic reactions during therapy. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Montelukast can interact with other medicines; some interactions require avoidance while others need monitoring.

Major Interactions (Avoid): - Phenobarbital: induces metabolism, reducing efficacy. - Rifampin: strong enzyme inducer, may lower plasma levels. - Ketoconazole: may increase levels, risk of toxicity.

Moderate Interactions (Monitor Closely): - Warfarin: possible alteration of anticoagulant effect. - Theophylline: may increase plasma concentrations. - Beta‑agonists: additive bronchodilation effect.